Our leadership is deeply embedded in the industry and supported by an Advisory Board of experts from every sector that we serve.
Staying at the cutting edge of every change in the market allows us to deliver the right candidates for your business and provide invaluable counsel no matter how unique your needs.
Founded in 2000, Slone Partners is a premier executive search firm that specializes in recruitment for companies focused in biotechnology, pharma services, life science tools, diagnostics, genomics, clinical services, medical devices, data and analytics, and food sciences.
Life sciences-focused search firm Slone Partners has expanded its footprint in the private equity, healthcare, and non-profit executive search markets with the promotion of two senior leaders. Bridget Burke, who previously served as the firm’s chief business officer, has been named senior vice president & practice leader, healthcare, non-profits & social impact, and Kate Portland has been
Life sciences-focused search firm Slone Partners has placed Gregory C. Critchfield as co-CEO of EarlyDiagnostics (EarlyDx), a leading company in liquid biopsy methylome detection of early cancer. “Greg Critchfield is a highly accomplished and respected life sciences executive with the deep knowledge and experience needed to drive a growth-focused company forward,” said Leslie Loveless, managing partner and
Life sciences-focused search firm Slone Partners has recruited Jeremy Bender, Teresa Bitetti, and David Meek as members of the board of directors at Fusion Pharmaceuticals, a clinical-stage biopharmaceutical company developing next-generation radiopharmaceuticals as precision medicines for the treatment of cancer. “Jeremy Bender, Teresa Bitetti, and David Meek are all very accomplished and highly respected leaders in the fields of biopharmaceuticals, oncology,
Life sciences-focused search firm Slone Partners has placed Christophe Arbet-Engels as chief medical officer at X4 Pharmaceuticals Inc., a public biopharmaceutical company. The enterprise is developing novel small molecule therapeutics to benefit patients with diseases of the immune system. Dr. Arbet-Engels previously served as CMO at several life science companies, including Neurogastrx, Millendo Therapeutics, and Poxel Pharmaceuticals,
September 13, 2023 – Slone Partners, a nationwide executive search firm for life sciences, healthcare, and cybersecurity organizations, announced the placement of Cynthia Pussinen as chief executive officer (CEO) and a member of the board of directors at Sernova Corporation, a clinical-stage company and leader in cell therapeutics. Pussinen’s expertise spans the drug development continuum from research
SOUTH RIDING, VA. – August 31, 2023 – Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and healthcare companies, today announced the successful placement of Christophe Arbet-Engels, MD, PhD, as chief medical officer (CMO) at X4 Pharmaceuticals, Inc., a biopharmaceutical company developing novel small molecule therapeutics to benefit patients with diseases of the immune system.
SOUTH RIDING, VA. – August 22, 2023 –Slone Partners, a nationwide executive search firm for life sciences, biotechnology, healthcare and cybersecurity companies, has been designated as a Certified LGBT Business Enterprise™ (LGBTBE®) by the National LGBT Chamber of Commerce (NGLCC), providing the company with a wide range of exciting new business and partnership opportunities. “This designation
SOUTH RIDING VA. – July 11, 2023 – Slone Partners, one of the nation’s leading life sciences and healthcare executive search firms, recently announced the appointment of Mike Mosunic as president of Slone Partners Cybersecurity, its subsidiary that delivers leaders for innovative private equity (PE)-backed and venture capital (VC) companies in the cybersecurity industry. Mosunic is an
SOUTH RIDING, VA. – May 18, 2023 – Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and healthcare companies, has announced the placement of Bret Christensen as President, Chief Executive Officer (CEO), and member of the Board of Directors at DermTech, a leader in precision dermatology enabled by a non-invasive skin genomics platform. Christensen comes to DermTech
Thought Leadership
Elevating Executive Presence: A Blueprint for Life Sciences and Biotech Leaders
What’s Next in Precision Medicine: Leadership Challenges and Opportunities
Full-Time vs. Fractional Talent: What’s the Best Fit for Your Organization?
Fractional Talent On Demand: The Slone Partners Difference
Life Sciences Leadership, Redefined: What Boards are Looking for in 2025